Spontaneous improvement of untreated mild Graves' ophthalmopathy: Rundle's curve revisited

Thyroid

Volumn 24, Issue 1, 2014, Pages 60-66

  Menconi, Francesca ^a   Profilo, Maria Antonietta ^a   Leo, Marenza ^a   Sisti, Eleonora ^a   Altea, Maria Antonietta ^a   Rocchi, Roberto ^a   Latrofa, Francesco ^a   Nardi, Marco ^a   Vitti, Paolo ^a   Marcocci, Claudio ^a   Marinò, Michele ^a  

^a UNIVERSITY HOSPITAL OF PISA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

RADIOACTIVE IODINE; THIAMAZOLE; THYROTROPIN RECEPTOR ANTIBODY;

ADOLESCENT; ADULT; AGED; ARTICLE; AUTOIMMUNE THYROIDITIS; CLINICAL ACTIVITY SCORE; CLINICAL FEATURE; CLINICAL OBSERVATION; DIPLOPIA; DISEASE ACTIVITY; DISEASE DURATION; DISEASE SEVERITY; ENDOCRINE OPHTHALMOPATHY; EXOPHTHALMOS; EYE EXAMINATION; EYELID; FEMALE; GRAVES DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MODEL; NOSPECS SCORE; ORGAN SIZE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RUNDLE CURVE; SCORING SYSTEM; SMOKING HABIT; THYROID DISEASE; THYROIDECTOMY; VERY ELDERLY; VISUAL ACUITY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; GRAVES OPHTHALMOPATHY; HUMANS; MALE; MIDDLE AGED; REMISSION, SPONTANEOUS; RETROSPECTIVE STUDIES;

EID: 84892167611     PISSN: 10507256     EISSN: 15579077     Source Type: Journal    
DOI: 10.1089/thy.2013.0240     Document Type: Article

References (29)

1. Bahn RS 2010 Graves' orbitopathy. N Engl J Med 362: 726-738
2. Bartalena L, Tanda ML 2009 Clinical practice. Graves' orbitopathy. N Engl J Med 360:994-1001
3. Bartalena L, Pinchera A, Marcocci C 2000 Management of Graves' ophthalmopathy: Reality and perspectives. Endocr Rev 212:168-199
4. Bartalena L, Wiersinga WM, Pinchera A 2004 Graves' orbitopathy: State of the art and perspectives. J Endocrinol Invest 27:295-301
5. Marcocci C, Marinò M 2012 Treatment of mild, moderate-Tosevere and very severe Graves' orbitopathy. Best Pract Res Clin Endocrinol Metab 26:325-337
6. Marcocci C, Pinchera A, Marinò M 2007 A treatment strategy for Graves' orbitopathy. Nat Clin Pract Endocrinol Metab 3:430-436
7. Bartley GB 2011 Rundle and his curve. Arch Ophthalmol 129:356-358
8. Wiersinga WM 1992 Immunosuppressive treatment of Graves' ophthalmopathy. Thyroid 2:229-233
9. Perros P, Kendall-Taylor P 1998 Natural history of thyroid eye disease. Thyroid 8:423-425
10. Rundle FF, Wilson CW 1945 Development and course of exophthalmos and ophthalmoplegia in Graves' disease with special reference to the effect of thyroidectomy. Clin Sci 5:177-194
11. Rundle FF 1957 Management of exophthalmos and related ocular changes in Graves' disease. Metabolism 6:36-48
12. Teng CS, Yeo PP 1977 Ophthalmic Graves' disease: Natural history and detailed thyroid function studies. Br Med J 29:273-275
13. Perros P, Crombie AL, Kendall-Taylor P 1995 Natural history of thyroid associated ophthalmopathy. Clin Endocrinol (Oxf) 42:45-50
14. Streeten DH, Anderson GH Jr, Reed GF, Woo P 1987 Prevalence, natural history and surgical treatment of exophthalmos. Clin Endocrinol (Oxf) 27:125-133
15. Noth D, Gebauer M, Müller B, Bürgi U, Diem P 2001 Graves' ophthalmopathy: Natural history and treatment outcomes. Swiss Med Wkly 131:603-609
16. Marcocci C, Kahaly GJ, Krassas GE, Bartalena L, Prummel M, Stahl M, Altea MA, Nardi M, Pitz S, Boboridis K, Sivelli P, von Arx G, Mourits MP, Baldeschi L, Bencivelli W, Wiersinga W; European Group on Graves' Orbitopathy 2011 Selenium and the course of mild Graves' orbitopathy. N Engl J Med 364:1920-1931
17. Tanda ML, Piantanida E, Liparulo L, Veronesi G, Lai A, Sassi L, Pariani N, Gallo D, Azzolini C, Ferrario M, Bartalena L. 2013 Prevalence and natural history of Graves' orbitopathy in a large series of patients with newly diagnosed Graves' hyperthyroidism seen at a single center. J Clin Endocrinol Metab 98:1443-1449
18. Mourits MP, Prummel MF, Wiersinga WM, Koornneef L 1997 ClinicalActivity Score as a guide in themanagement of patients with Graves' ophthalmopathy. Clin Endocrinol (Oxf) 47:9-14
19. Bartalena L, Baldeschi L, Dickinson AJ, Eckstein A, Kendall-Taylor P, Marcocci C, Mourits MP, Perros P, Boboridis K, Boschi A, Currò N, Daumerie C, Kahaly GJ, Krassas G, Lane CM, Lazarus JH, Marinò M, Nardi M, Neoh C, Orgiazzi J, Pearce S, Pinchera A, Pitz S, Salvi M, Sivelli P, Stahl M, von Arx G, Wiersinga WM 2008 Consensus statement of the European group on Graves' orbitopathy (EUGOGO) on management of Graves' orbitopathy. Thyroid 18:333-346
20. Werner SC 1977 Modification of the classification of the eye changes of Graves' disease: Recommendations of the Ad Hoc Committee of the American Thyroid Association. J Clin Endocrinol Metab 44:203-204
21. Profilo MA, Sisti E, Marcocci C, Vitti P, Pinchera A, Nardi M, Rocchi R, Latrofa F, Menconi F, Altea MA, Leo M, Rago T, Marinò M 2013 Thyroid volume and severity of Graves' orbitopathy. Thyroid 23:97-102
22. Eckstein A, Esser J, Mann K, Schott M 2010 Clinical value of TSH receptor antibodies measurement in patients with Graves' orbitopathy. Pediatr Endocrinol Rev 7:198-203
23. Bartalena L, Marcocci C, Bogazzi F, Panicucci M, Lepri A, Pinchera A 1989 Use of corticosteroids to prevent progression of Graves' ophthalmopathy after radioiodine therapy for hyperthyroidism. N Engl J Med 321:1349-1352
24. Tallstedt L, Lundell G, Torring O, Wallin G, Ljunggren J-G, Blomgren H, Taube A, and the Thyroid Study Group 1992 Occurrence of ophthalmopathy after treatment for Graves' hyperthyroidism. N Engl J Med 326:1733-1738
25. Tallstedt L, Lundell G, Blomgren H, Bring J 1994 Does early administration of thyroxine reduce the development of Graves' ophthalmopathy after radioiodine treatment? Eur J Endocrinol 130:494-497
26. Bartalena L, Marcocci C, Bogazzi F, Manetti L, Tanda ML, Dell'Unto E, Bruno-Bossio G, Nardi M, Bartolomei MP, Lepri A, Rossi G, Martino E, Pinchera A 1998 Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathy. N Engl J Med 338:73-78
27. Chiovato L, Latrofa F, Braverman LE, Pacini F, Capezzone M, Masserini L, Grasso L, Pinchera A 2003 Disappearance of humoral thyroid autoimmunity after complete removal of thyroid antigens. Ann Int Med 139:346-351
28. Menconi F, Marinò M, Pinchera A, Rocchi R, Mazzi B, Nardi M, Bartalena L, Marcocci C 2007 Effects of total thyroid ablation versus near-Total thyroidectomy alone on mild to moderate Graves' orbitopathy treated with intravenous glucocorticoids. J Clin Endocrinol Metab 92:1653-1658
29. Leo M, Marcocci C, Pinchera A, Nardi M, Megna L, Rocchi R, Latrofa F, Altea MA, Mazzi B, Sisti E, Profilo MA, Marinò M 2012 Outcome of Graves' Orbitopathy after total thyroid ablation and glucocorticoid treatment: Follow-up of a randomized clinical trial. J Clin Endocrinol Metab 97:E44-E48